Literature DB >> 21877121

Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.

Sara E Wagner1, Bettina F Drake, Keith Elder, James R Hébert.   

Abstract

OBJECTIVE: To assess social and clinical influences of prostate cancer treatment decisions among white and black men in the Midlands of South Carolina.
METHODS: We linked data collected on treatment decision making in men diagnosed with prostate cancer from 1996 through 2002 with clinical and sociodemographic factors collected routinely by the South Carolina Central Cancer Registry (SCCCR). Unconditional logistic regression was used to assess social and clinical influences on treatment decision.
RESULTS: A total of 435 men were evaluated. Men of both races who chose surgery (versus radiation) were more likely to be influenced by their physician and by family/friends. Black men who chose surgery also were ~5 times more likely to make independent decisions (i.e., rather than be influenced by their doctor). White men who chose surgery were twice as likely to be influenced by the desire for cure and less likely to consider the side effects of impotence (odds ratio (OR) = 0.40; 95% confidence interval (CI): 0.18, 0.88) and incontinence (OR = 0.27; 95% CI: 0.12, 0.63); by contrast, there was a suggestion of an opposite effect in black men, whose decision regarding surgery tended to be more strongly influenced by these side effects.
CONCLUSION: Results suggest that both clinical and social predictors play an important role for men in choosing a prostate cancer treatment, but these influences may differ by race.

Entities:  

Mesh:

Year:  2011        PMID: 21877121      PMCID: PMC3383650          DOI: 10.1007/s10552-011-9836-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

1.  From "death sentence" to "good cancer": couples' transformation of a prostate cancer diagnosis.

Authors:  Sally L Maliski; MarySue V Heilemann; Ruth McCorkle
Journal:  Nurs Res       Date:  2002 Nov-Dec       Impact factor: 2.381

2.  Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid.

Authors:  Deb Feldman-Stewart; Michael D Brundage; Lori Van Manen; Ola Svenson
Journal:  Health Expect       Date:  2004-06       Impact factor: 3.377

3.  Patient preferences for management of localized prostate cancer.

Authors:  D J Mazur; D H Hickam
Journal:  West J Med       Date:  1996 Jul-Aug

4.  Treatment decision-making by men with localized prostate cancer: the influence of personal factors.

Authors:  Donna L Berry; William J Ellis; Nancy Fugate Woods; Christina Schwien; Kristin H Mullen; Claire Yang
Journal:  Urol Oncol       Date:  2003 Mar-Apr       Impact factor: 3.498

5.  Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.

Authors:  A Chapple; S Ziebland; A Herxheimer; A McPherson; S Shepperd; R Miller
Journal:  BJU Int       Date:  2002-08       Impact factor: 5.588

6.  Partner's influence on patient preference for treatment in early prostate cancer.

Authors:  S J Srirangam; E Pearson; C Grose; S C W Brown; G N Collins; P H O'Reilly
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

7.  Information and decision-making preferences of men with prostate cancer.

Authors:  B J Davison; L F Degner; T R Morgan
Journal:  Oncol Nurs Forum       Date:  1995-10       Impact factor: 2.172

8.  Preferences of husbands and wives for outcomes of prostate cancer screening and treatment.

Authors:  Robert J Volk; Scott B Cantor; Alvah R Cass; Stephen J Spann; Susan C Weller; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

9.  Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Authors:  Arnold L Potosky; William W Davis; Richard M Hoffman; Janet L Stanford; Robert A Stephenson; David F Penson; Linda C Harlan
Journal:  J Natl Cancer Inst       Date:  2004-09-15       Impact factor: 13.506

10.  Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Authors:  Richard M Hoffman; Linda C Harlan; Carrie N Klabunde; Frank D Gilliland; Robert A Stephenson; William C Hunt; Arnold L Potosky
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

View more
  6 in total

1.  Cancer mortality-to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants.

Authors:  Sara E Wagner; Deborah M Hurley; James R Hébert; Chrissy McNamara; A Rana Bayakly; John E Vena
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

2.  African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Authors:  Augustine C Obirieze; Ambria Moten; Delenya Allen; Chiledum A Ahaghotu
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-16

3.  Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice.

Authors:  Louie E Ross; Daniel L Howard; Janice V Bowie; Roland J Thorpe; Ballington L Kinlock; Carol Burt; Thomas A LaVeist
Journal:  J Cancer Educ       Date:  2016-06       Impact factor: 2.037

4.  Colon cancer treatment: are there racial disparities in an equal-access healthcare system?

Authors:  Abegail A Gill; Lindsey Enewold; Shelia H Zahm; Craig D Shriver; Alexander Stojadinovic; Katherine A McGlynn; Kangmin Zhu
Journal:  Dis Colon Rectum       Date:  2014-09       Impact factor: 4.585

5.  Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.

Authors:  Elyse Reamer; Felix Yang; Margaret Holmes-Rovner; Joe Liu; Jinping Xu
Journal:  Biomed Res Int       Date:  2017-07-12       Impact factor: 3.411

6.  Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.

Authors:  Jinping Xu; Michael Goodman; James Janisse; Michael L Cher; Cathryn Hufford Bock
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.